Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation
Abstract Gastric cancer (GC) therapies are limited by severe adverse effects. Galangin, a natural flavonoid from galangal, shows anticancer activity, but its efficacy and mechanisms against GC remain incompletely defined. We evaluated galangin against GC in vitro and in vivo, focusing on PI3K/AKT/mTOR signaling. Galangin inhibited proliferation and migration of SNU719 and MKN45 cells while sparing GES-1 epithelial cells. In xenografts, galangin (60–120 mg/kg/day) significantly and dose-dependently suppressed tumor growth. Galangin elevated intracellular reactive oxygen species (ROS), reduced mitochondrial membrane potential, and triggered caspase-3 activation and mitochondrial apoptosis. Transcriptomic and network pharmacology analyses implicated PI3K/AKT/mTOR, apoptosis, cell cycle, and p53 pathways; immunoblotting and immunohistochemistry confirmed pathway inhibition in cells and tumors, respectively. These findings support galangin as a multitarget anti-GC candidate with a favorable safety profile relative to 5-FU.
Authors
- Yingzi Wu (ORCID: https://orcid.org/0000-0002-6174-0796)
- Baojun Xu (ORCID: https://orcid.org/0000-0003-0739-3735)
- Jian-Min Luo (ORCID: https://orcid.org/0009-0007-6541-8685)
- Bo Han (ORCID: https://orcid.org/0009-0001-3706-242X)
- Jinhai Luo (ORCID: https://orcid.org/0000-0003-0183-160X)
Institutions
- Beijing Normal-Hong Kong Baptist University (CN)
- Hong Kong Baptist University (HK)
- Guangzhou College of Technology and Business (CN)
Publication Details
- Journal
- Journal of Agricultural and Food Chemistry
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1021/acs.jafc.6c06698
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Education of Guangdong Province